These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17414633)

  • 1. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):36-40. PubMed ID: 10697043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital.
    Langenberg M; Terhaard CH; Hordijk GJ; Es RJ; Voest EE; Graeff A
    Clin Otolaryngol Allied Sci; 2004 Dec; 29(6):729-34. PubMed ID: 15533169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
    Specenier PM; Vermorken JB
    Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
    Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
    Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
    Gilbert J; Argiris A
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
    Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
    Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
    Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
    Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease.
    Clark JR; Frei E
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.